24 件 ・ 関連度順
概要と使いどころ
TAM/SAM/SOM calculator with deep market research. Produces comprehensive market-sizing.md with top-down and bottom-up estimates, methodology, data sources, assumptions, sensitivity ranges, growth projections, competitive landscape, and Mermaid visualizations. Use when user needs market size estimates, addressable market analysis, go-to-market sizing, investor-ready market analysis, or business plan market validation.
日本語の概要は準備中です。原文の説明を表示しています。
Skill for saas-market-sizing tasks.
日本語の概要は準備中です。原文の説明を表示しています。
Calculate TAM/SAM/SOM for market opportunities using top-down, bottom-up, and value theory methodologies. Use this skill when sizing markets, estimating addressable revenue, validating market opportunity for a new venture, or building investor-ready market analysis for a startup pitch or business plan.
日本語の概要は準備中です。原文の説明を表示しています。
Use when doing upstream market-research methodology — sizing a market as TAM/SAM/SOM computed BOTH top-down and bottoms-up (never a single unsourced number), planning a survey sample size with finite-population correction and per-segment minimums, or scoring candidate market segments against Kotler's measurable/substantial/accessible/differentiable/actionable criteria. Outputs always show the method and the assumptions. For market-research analysts and product-marketing at the sizing/survey/segmentation moment. Distinct from marketing-skill (campaign analytics, attribution, demand-gen) — this is the evidence-building methodology, not live-campaign optimization.
日本語の概要は準備中です。原文の説明を表示しています。
Estimate market size using TAM, SAM, and SOM with top-down and bottom-up approaches. Use when sizing a market opportunity, estimating addressable market, preparing for investor pitches, or evaluating market entry.
日本語の概要は準備中です。原文の説明を表示しています。
Estimate market, segment, or opportunity size with transparent assumptions and uncertainty. Use for TAM/SAM/SOM, sizing scenarios, or comparing the scale of possible opportunities.
日本語の概要は準備中です。原文の説明を表示しています。
This skill should be used when the user asks to "calculate TAM", "determine SAM", "estimate SOM", "size the market", "calculate market opportunity", "what's the total addressable market", or requests market sizing analysis for a startup or business opportunity.
日本語の概要は準備中です。原文の説明を表示しています。
This skill should be used when the user asks to "calculate TAM", "determine SAM", "estimate SOM", "size the market", "calculate market opportunity", "what's the total addressable market", or requests market sizing analysis for a startup or business opportunity.
日本語の概要は準備中です。原文の説明を表示しています。
Market sizing and market structure work — TAM/SAM/SOM built top-down and bottom-up then reconciled, segmentation, demand triangulation, and survey design. Use when sizing a market, writing a sizing memo, or fielding a survey.
日本語の概要は準備中です。原文の説明を表示しています。
Patient-flow market sizing for med products — prevalence → diagnosed → interested → affordable → covered → treated → persistent, priced as price × duration per cohort, with capacity constraints, named historical analog anchoring, and always bull/base/bear named-driver grids. Use to size a therapy area or product market before any valuation or share work.
日本語の概要は準備中です。原文の説明を表示しています。
Calculate TAM/SAM/SOM for market opportunities using top-down, bottom-up, and value theory methodologies. Use this skill when sizing markets, estimating addressable revenue, validating market opportunity for a new venture, or building investor-ready market analysis for a startup pitch or business plan.
日本語の概要は準備中です。原文の説明を表示しています。
Estimate market size using TAM, SAM, and SOM with top-down and bottom-up approaches. Use when sizing a market opportunity, estimating addressable market, preparing for investor pitches, or evaluating market entry.
日本語の概要は準備中です。原文の説明を表示しています。
Builds credible TAM/SAM/SOM analysis with external validation and sensitivity testing for startup fundraising: top-down, bottom-up, or both. Use when the user asks to size a market or check market claims and gives something to size: a product or service description, a market segment, or a deck with TAM/SAM/SOM claims. A full run takes about 15–20 minutes and searches the web, 30 or more with a large data room or a revision round, so for a passing question about market size, answer briefly in chat and offer the analysis instead of starting it. When it runs, every figure is externally sourced and stress-tested, never estimated from memory.
日本語の概要は準備中です。原文の説明を表示しています。
把多页 HTML 报告(主页 + N 子页 + PNG 资产)合并为单一独立 HTML / PDF / XLSX 三件交付物。 Use when finalizing a disease market sizing report and need shareable deliverables — single-file HTML for email/IM(零依赖,双击浏览器开), optional PDF for print/archive, XLSX for data export. 领域无关、跨疾病通用。 下游 of disease-market-sizing-html-template;上游 of email/IM/print 分发。 Use proactively whenever the user says "做交付物" / "生成 PDF" / "导 Excel" / "合并单文件 HTML"。
日本語の概要は準備中です。原文の説明を表示しています。
Mid-run failure recovery for disease-market-sizing-orchestration. Inspects .cache/<slug>/ to determine which phase last completed and which phase to run next. Use when orchestration was interrupted and user wants to continue without restarting from phase 1.
日本語の概要は準備中です。原文の説明を表示しています。
中国药品权威数据库查询 — NMPA(国家药监局) + CDE(药品审评中心) + DrugBank(英文名/ATC) + PubChem(化学结构) 多源融合,提供(通用名 ↔ 商品名 ↔ 英文名 ↔ 适应症 ↔ NMPA 批文号 ↔ 上市日期)精确映射。Make sure to use this skill whenever the user mentions 药品名 / 通用名 / 商品名 / NMPA / 国药准字 / 药监局 / CDE / drug brand name / generic name / drug registry / pharmaceutical lookup / drug verification / 药物核验 / 商品名对应 / drug cross-check / drug authority lookup. 在任何 medical / market-sizing / clinical / disease-research 报告生成阶段,**所有药品提及必须先调 lookup_drug() 验证**,严禁 LLM 凭训练记忆拼凑通用名↔商品名↔英文名对应关系。LLM 训练截止后药企会更换商品名、新药持续上市,记忆完全不可信。Iron Law:lookup 返回 None → 调用方必须 raise UnverifiedDrugError,不允许 fallback 到记忆。免费公开数据源,跨平台:Claude Code / Codex / Gemini CLI 三端均可 auto-trigger,实现仅依赖 httpx + beautifulsoup4 标准生态,不绑定任何厂商 SDK。
日本語の概要は準備中です。原文の説明を表示しています。
Phase 5 part of disease-market-sizing-orchestration. Injects consulting palette (navy/gold/blue) + base CSS + floating TOC + section dividers into raw report HTML. Validates token coverage ≥60% (warn) and floating TOC li ≥5 (block). Use AFTER content-verification passes, BEFORE report-bundle-builder build_all_deliverables.
日本語の概要は準備中です。原文の説明を表示しています。
Phase 2 of disease-market-sizing-orchestration. Discovers disease-specific stratification dimensions by citing guideline sections from sources/guidelines/. ALWAYS uses cite-based discovery — NEVER built-in stratification templates. Output: .cache/<slug>/staging.json. Use AFTER contract-elicitor and AFTER A1' guidelines fetch.
日本語の概要は準備中です。原文の説明を表示しています。
Use FIRST when user requests any disease market sizing report (e.g. "做 X 市场调研" / "Run market sizing for X"). Elicits 4-6 startup questions (evidence window, geography, international comparison, report depth, user role) and writes .cache/<slug>/contract.json. ALWAYS invoke before disease-market-sizing-orchestration. Validates against schemas/contract.schema.json.
日本語の概要は準備中です。原文の説明を表示しています。
Phase 4 Turn 2 of disease-market-sizing-orchestration (A6' upgrade). Audits compose output via Cite-or-Block strict — every anchor must reverse-resolve to an actual file in sources/, every fact claim must have an anchor. Returns verdict (ok/blocked) + violations list. Use AFTER cite-bound-content-generator (Turn 1), BEFORE report-bundle-builder (phase 5).
日本語の概要は準備中です。原文の説明を表示しています。
Phase 4 Turn 1 of disease-market-sizing-orchestration. Generates report HTML with mandatory citation anchors per fact claim. Reads contract + staging + sources/. Every drug/treatment/stat/recommendation MUST carry [pmid:.../guideline:.../nct:...] anchor that resolves to an actual file in sources/. NEVER hardcode drug names or numerical claims. Use AFTER evidence recall (phase 3), BEFORE content-verification-layer (Turn 2).
日本語の概要は準備中です。原文の説明を表示しています。
Cross-disease market sizing entry skill. Triggered by user one-liner like "做 X 市场调研" or "Run market sizing for X". Auto-runs 5 phase pipeline: contract → stratify → recall → compose-audit → bundle. Hard-gates on Cite-or-Block: every fact claim must carry citation anchor verifiable against sources/. Resumable mid-run.
日本語の概要は準備中です。原文の説明を表示しています。
Comprehensive market sizing methodologies for calculating Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) for startup opportunities.
日本語の概要は準備中です。原文の説明を表示しています。
Calculate TAM, SAM, and SOM for new market segments using top-down and bottom-up methods
日本語の概要は準備中です。原文の説明を表示しています。